Myriad Genetics (MYGN) – Downgrades
-
BofA/Merrill Lynch Downgrades Myriad Genetics (MYGN) to Underperform
-
Barclays Downgrades Myriad Genetics (MYGN) to Underweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MYGN Stock Lookup